Cadrenal Therapeutics CEO Quang X. Pham to participate in H.C. Wainwright conference
Cadrenal Therapeutics said CEO Quang X. Pham will participate in H.C. Wainwright's 28th Annual Global Investment Conference.
PONTE VEDRA, Fla., Sept.
03, 2026 (GLOBE NEWSWIRE) -- Cadrenal Therapeutics, Inc.
NASDAQ:CVKD, a late-stage biopharmaceutical company advancing specialized therapies for critical care cardiology and orphan cardiovascular conditions, announced that CEO Quang X.
Pham will participate in the 28th Annu…